SAM
INDV icon

Smartleaf Asset Management’s Indivior Pharmaceuticals INDV Stock Holding History

Smartleaf Asset Management’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.9K Hold
337
– – ﹤0.01% 2199
2026
Q1 		$9.7K Buy
337
+217
+181% +$7.17K ﹤0.01% 2346
2025
Q4 		$4.29K Buy
120
+109
+991% +$3.33K ﹤0.01% 2765
2025
Q3 		$265 Buy
+11
New +$230 ﹤0.01% 2923

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Smartleaf Asset Management's INDV Position: Q2 2026 in Review

Smartleaf Asset Management held its Indivior Pharmaceuticals (INDV) position steady in Q2 2026 at 337 shares worth $13.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2199.

Smartleaf Asset Management first reported a position in INDV in Q3 2025 and has held it in 4 quarters since. 338 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Smartleaf Asset Management held 337 shares of Indivior Pharmaceuticals worth $13.9K as of Q2 2026.
  • Smartleaf Asset Management left its Indivior Pharmaceuticals share count unchanged in Q2 2026.
  • Indivior Pharmaceuticals made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #2199 holding.
  • Smartleaf Asset Management first reported a position in Indivior Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 338 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.